But LUN-DE ZHAO and others and Si Chen, et al. showed that miR-181b could act as a tumor suppressor in CRC by targeting RASSF1A [34] and regulating TUSC3 [14], respectively. The gene discussed is RASSF1; the disease is colorectal carcinoma.